A61L27/3895

System and Method for Creating Tissue

A system and method for growing and maintaining biological material including producing a protein associated with the tissue, selecting cells associated with the tissue, expanding the cells, creating at least one tissue bio-ink including the expanded cells, printing the at least one tissue bio-ink in at least one tissue growth medium mixture, growing the tissue from the printed at least one tissue bio-ink, and maintaining viability of the tissue.

SCHWANN CELLS AND METHOD FOR PREPARING SAME

The present invention addresses the problem of providing a method for obtaining Schwann cells directly (by direct reprogramming) without passing through pluripotent stem cells, such as ES cells or iPS cells. As a means for solving this problem, the present invention provides a method for preparing Schwann cells that includes a step of introducing into somatic cells of a mammal at least one gene selected from the group consisting of SOX10 genes and KROX20 genes, or an expression product thereof.

NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY

A composite material can include a gel and at least one nanostructure disposed within the gel. A method for healing a soft tissue defect can include applying a composite material to a soft tissue defect, wherein the composite material includes a gel and a nanostructure disposed within the gel. A method for manufacturing a composite material for use in healing soft tissue defects can include providing a gel and disposing nanofibers within the gel.

COMPOSITION FOR TRANSPLANTATION OF ORGANOID

The present invention relates to a composition for transplantation comprising an organoid, and a use of same. According to one example, using collagen, gelatin or fibrin glue as a scaffold for organoid transplantation results in a high transplantation rate and a high survival rate of organoid as well as desirable stability.

CELL STRUCTURE, CELL CULTURE, AND MANUFACTURING METHOD OF A CELL STRUCTURE

The present disclosure aims to provide a manufacturing method of a cell structure. The manufacturing method comprises a preparation step of preparing, on a culturing surface of a cell culture container, a first coated region coated with a temperature-responsive polymer and/or a temperature-responsive polymer composition, and a plurality of second coated regions located at an edge of the first coated region and coated with a cell adhesive substance; and a seeding and culturing step of seeding cells in the first coated region and the second coated regions and culturing the cells to produce a cell structure.

System and Method for Creating Tissue

A system and method for growing and maintaining biological material including producing a protein associated with the tissue, selecting cells associated with the tissue, expanding the cells, creating at least one tissue bio-ink including the expanded cells, printing the at least one tissue bio-ink in at least one tissue growth medium mixture, growing the tissue from the printed at least one tissue bio-ink, and maintaining viability of the tissue.

COMPOSITIONS AND METHODS FOR CRYOPRESERVATION AND RECONSTITUTION OF ENGINEERED TISSUES

Systems, methods, and compositions for cryopreservation and reconstitution of engineered tissues. The engineered tissue compositions are functional after a cryopreservation-thaw cycle For example, the tissue compositions retain their structural integrity, maintain cell-cell communication, etc. In certain embodiments, the tissue compositions exhibit synchronous contractions, secrete a hormone, secrete a cytokine, secrete an RNA, secrete a growth factor, secrete an enzyme, and/or secrete a neurotransmitter, etc. in some embodiments, engineered tissue compositions are cultured, cryopreserved, and reconstituted in a closed system.

CORE-SHELL STRUCTURE FOR ESTABLISHING NORMAL AND CANCER ORGANOID MICROENVIRONMENT AND FABRICATION METHOD THEREFOR

Proposed is a core-shell structure including a shell portion and a core portion, in which the shell portion includes n shells that are sequentially located from outside to inside, the core portion includes a core located inside the shell portion, n is any one of natural numbers from 1 to 30, when n is 1, the core is located adjacent to the inside of a first shell, when n is any one of natural numbers from 2 to 30, an n.sup.th shell is located adjacent to the inside of an n−1.sup.th shell, the n.sup.th shell is an empty space or is a hydrogel including at least one of an n.sup.th extracellular matrix and an n.sup.th cell, the core is an empty space or is a hydrogel including at least one of an extracellular matrix for a core and a cell for a core, two of the n shells and the core that are in contact with each other are not empty spaces simultaneously, and densities of the two of the n shells and the core that are in contact with each other are identical or different, thereby mimicking the construction of hollow organs such as the stomach, intestines, bladder, and lungs.

Use of poly(alkylene terephthalates) and methods for their preparation

The present invention relates to poly(alkylene terephthalate) polyesters having long poly-methylene segments and their use in a wide variety of applications. Particularly, said PAT polyesters are used in biotechnological or biomedical applications, wherein the extent of cell adhesion, cell growth or cell interaction, in particular endothelial cells, depends on the odd or even number of carbon atoms in the aliphatic segments. Also provided are methods for the preparation of poly(alkylene terephthalates) (PAT) having long poly-methylene segments, wherein the bifunctional monomers, in particular terephthalic acid (or a derivative thereof) and an aliphatic diol, are dissolved in a solvent and the polycondensation reaction takes place in solution.

CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS

The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.